Village Farms’ Harvest of Cash: Q2 2026 Signals Growth in Cannabis and International Expansion

Executive snapshot

• Net sales: $64 million, up 27% sequentially and 7% year over year.
• Net income: $7.1 million, or $0.06 per share.
• Operating cash flow (OCF): $8.9 million.
• Cannabis revenue (quarter): $53.5 million, driving the bulk of the top line.
• Adjusted EBITDA (continuing ops): $15.3 million, or 29% of sales; $15.4 million if you exclude a one-time vendor settlement from the prior year.
• Export sales: $20.9 million, up 74% year over year and 43% sequentially.
• Liquidity: $73 million in cash at quarter end; Netherlands and Canadian expansion CapEx nearing completion.

Operational highlights

The company highlights robust performance from its cannabis segment, with the quarter delivering record cannabis revenues that supported positive net income and EBITDA expansion. Management noted improved cost of production at Delta facilities, contributing to stronger year-to-date harvest yields in the first half of 2026. The delta in production efficiency is paired with sustained export momentum, underscoring Village Farms’ push into high-growth markets beyond conventional domestic channels.

Capital expenditures tied to Netherlands and Canada expansion are nearly complete, helping to position the company for deeper international scale. The balance sheet remains cash-rich, with $73 million on hand as of quarter end, reinforcing liquidity as the company navigates ongoing capacity investments and potential regulatory shifts in its key markets.

Management commentary

CEO Michael DeGiglio framed the quarter as evidence of Village Farms’ expanding global cannabis platform, noting record cannabis revenues and the ongoing transition to a profitable growth phase. He highlighted the fifth consecutive quarter of positive net income and earnings per share since privatizing the legacy produce business, and he pointed to the adjusted EBITDA trajectory when excluding a one-time vendor settlement from the prior year. Taken together, the remarks suggest management believes the company is entering a more sustainable operating rhythm, even as it continues to invest in scale.

Financial analysis: what the numbers imply

The sequential and year-over-year top-line gains reflect a mix of cannabis growth and expanding export channels. A cannabis-driven EBITDA margin of 29% signals a surprisingly healthy operating leverage within a sector that often contends with price pressure and regulatory uncertainty. Excluding the $4.3 million one-time vendor settlement from the prior year, adjusted EBITDA would be $15.4 million, amplifying the sense that core operations are delivering consistent profitability beyond one-off items.

The Q2 cadence also underscores the importance of international exposure. Export sales rose dramatically, and the company notes continued progress in filling capacity in Delta facilities. The near-completion of expansion CapEx in the Netherlands and Canada should help sustain revenue momentum and potentially broaden gross margin opportunities if production costs continue to trend downward.

Market implications and sector view

For investors, the quarter offers more than a snapshot of Village Farms’ financials; it signals how a cannabis-focused producer might monetize scale and geographic diversification. The revenue mix—strong cannabis revenue, robust export growth, and improving production costs—points to a path where EPS could become more trajectory-driven rather than solely volume-driven. Analysts’ EPS consensus and revenue forecasts could shift higher if management sustains this cadence into the back half of 2026, especially if international sales contributions become more predictable and regulatory tailwinds remain constructive.

From a sector perspective, Village Farms’ progress may alter the calibration of profitability expectations among peers in Canada, the Netherlands, and broader international markets. The balance sheet strength, plus ongoing capex to expand output and improve cost structure, may press smaller growers to pursue faster international footprints or find niche markets where price discipline is achievable. The risk remains: regulatory changes, cross-border compliance, and currency dynamics could temper the pace of expansion or compress margins if input costs rise.

Outlook and risks

Village Farms appears positioned to sustain growth through the remainder of 2026, with a cash-rich balance sheet and capacity additions slated to contribute to revenue stability. The potential improvements in cost of production and continued expansion into export markets could support a firmer earnings trajectory and a more favorable EPS consensus trajectory, provided regulatory conditions stay favorable.

Key risks include regulatory tightening in cannabis markets, potential shifts in export regimes, and the usual industry headwinds of price competition and supply normalization as production capacity comes online. The company’s Italian-sweetened focus on high-margin cannabis products and international sales will be tested by how quickly it can translate volume into durable margin expansion.

Bottom line

Village Farms’ Q2 2026 results illustrate more than a quarterly performance beat; they reveal a company weaving together cannabis revenue growth, export momentum, and a improving cost structure under a cash-rich umbrella. For investors, the narrative now hinges on how sustainably this mix can translate into a steady EPS trajectory and how the revenue forecast evolves as international expansion matures. If the trajectory holds, the stock may see a re-rating as margin expansion compounds with top-line growth, even as the sector keeps investors mindful of regulatory and competitive risks.